Letter on '(1,3)-β-D-Glucan-based empirical antifungal interruption in suspected invasive candidiasis: a randomized trial'
Autor: | Antonios Kritikos, Frédéric Lamoth |
---|---|
Jazyk: | angličtina |
Rok vydání: | 2021 |
Předmět: |
Antifungal
medicine.medical_specialty business.industry medicine.drug_class MEDLINE lcsh:Medical emergencies. Critical care. Intensive care. First aid Invasive candidiasis lcsh:RC86-88.9 Critical Care and Intensive Care Medicine medicine.disease law.invention Randomized controlled trial law Internal medicine Medicine Antifungal Agents/therapeutic use Candidiasis Invasive/diagnosis Candidiasis Invasive/drug therapy Glucans Humans beta-Glucans business 1 3 β d glucan |
Zdroj: | Critical care, vol. 25, no. 1, pp. 55 Critical Care, Vol 25, Iss 1, Pp 1-3 (2021) |
Databáze: | OpenAIRE |
Externí odkaz: |